AngioDynamics, Inc. (NASDAQ:ANGO) EBITDA Improves
AngioDynamics, Inc. (NASDAQ:ANGO), a leader in transformative medical technology, stock rose 0.69% (As on July 16, 11:21:04 AM UTC-4, Source: Google Finance) after the company posted…
AngioDynamics, Inc. (NASDAQ:ANGO), a leader in transformative medical technology, stock rose 0.69% (As on July 16, 11:21:04 AM UTC-4, Source: Google Finance) after the company posted…
AngioDynamics, Inc. (NASDAQ:ANGO) stock fell 5.43% (As on April 3, 12:20:58 AM UTC-4, Source: Google Finance) after the company reported upbeat third-quarter earnings along with…
AngioDynamics, Inc. (NASDAQ:ANGO) stock fell 7.22% (As on October 4, 11:21:26 AM UTC-4, Source: Google Finance) after the company posted mixed results for the first…
AngioDynamics, Inc. (NASDAQ:ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and…
AngioDynamics, Inc. (NASDAQ:ANGO) stock fell 5.40% (As on October 5, 11:46:12 AM UTC-4, Source: Google Finance) after the company posted better than expected results for…
AngioDynamics, Inc. (NASDAQ:ANGO) stock rose 1.43% (As on July 13, 11:29:26 AM UTC-4, Source: Google Finance) after the company reported a Q4 loss of $21.46…
AngioDynamics, Inc. (NASDAQ:ANGO) stock plunges 13.03% (As on October 7, 11:56:31 AM UTC-4, Source: Google Finance) after the company reported a net loss of $13.00…
AngioDynamics, Inc. (NASDAQ:ANGO) stock rose 5.64% (As on July 13, 12:57:49 AM UTC-4, Source: Google Finance) after the company beaten the topline estimates for the…